OCUL · Ocular Therapeutix, Inc · Debt
$7.14
+0.32 (+4.69%)
At close · Nov 4
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Market Cap
$1.54B
Shares
219.62M
Volume · Nov 4
3.36M
Avg daily vol (3M)
3.04M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 3,122,000 | 10-Q filed 2026-08-03 |
| Noncurrent notes payable | 2026-06-30 | USD 72,795,000 | 10-Q filed 2026-08-03 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 3,466,000 | 10-Q filed 2026-08-03 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1393434
CUSIP
67576A100
13F (30d)
65 filings
65 filers
Visit website
Investor relations